BioSpace News Archive

Movano Inc., a health technology company designing devices that empower individuals to optimize their health in order to prevent and better manage chronic diseases, announced the pricing of its initial public offering of 8,500,000 shares of its common stock at a public offering price of $5.00 per share.

Halberd Corporation has compiled a number of third party published articles from various medical publications which support the selection of the various nutraceuticals in Halberd’s VITA-SHIELD-MAXTM Immune Booster.

Nuvo Group Ltd.—has partnered with University of Utah to study fetal heart rate variability

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer and other indications, today announced that it will host a full-year 2020 investor call on Tuesday, March 30, 2021 at 8:00 AM EDT to discuss financial results and provide a corporate update.

Arrakis Therapeutics , a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, announced today that it has appointed Amanda E. Hargrove, Ph.D., and Adrian Whitty, Ph.D., to its Scientific Advisory Board.

The Internal Brace Option™ is a viable alternative for treating progressive moderate scoliosis in adolescents and a game-changing treatment option for medical providers and patients to consider

CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2020, after the market close on Tuesday, March 30,

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, announced that the company will participate in panel and corporate presentations at the virtual Life Science Innovation Northwest Conference taking place March 30-31, 2021.

CarePoint Health and Rothman Orthopaedic Institute announced a five-year partnership to establish a world-class comprehensive orthopedic services institute at Hoboken University Medical Center and Christ Hospital in Jersey City.

SAN MATEO, Calif., March 23, 2021 /PRNewswire/ - Sierra Oncology, Inc., a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, granted a stock option to a new employee as approved by the Compensation Committee of the Company’s Board of Directors, under Sierra Oncology’s 2018 Equity Inducement Plan.